Effects of immunomodulators on airways hyperresponsiveness to adenosine induced in actively sensitised Brown Norway rats by exposure to allergen

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 368, Issue 1, 2003, Pages 17-25

  Tigani, Bruno ^a   Hannon, Jason P ^a   Schaeublin, Elisabeth ^a   Mazzoni, Lazzaro ^a   Fozard, John R ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adenosine; Airway hyperresponsiveness; Budesonide; IMM125; Mast cells; MLD987; Ovalbumin; SAR943

Indexed keywords

ADENOSINE DEAMINASE INHIBITOR; ALLERGEN; ASCOMYCIN; BRADYKININ; BUDESONIDE; CYCLOSPORIN A [8 DEXTRO O (2 HYDROXYETHYL)SERINE]; CYCLOSPORIN DERIVATIVE; DEXTRO SERINE CYCLOSPORINE; EOSINOPHIL PEROXIDASE; IMMUNOMODULATING AGENT; METHACHOLINE; MLD 987; MYELOPEROXIDASE; OVALBUMIN; RAPAMYCIN DERIVATIVE; SAR 943; SEROTONIN 1 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DRUG ANTAGONISM; ENZYME ACTIVITY; INFLAMMATION; LEUKOCYTE; LEUKOCYTE COUNT; LUNG LAVAGE; MALE; MAST CELL DEGRANULATION; NONHUMAN; RAT; RAT STRAIN; SEROTONIN RELEASE;

ADENOSINE; ADJUVANTS, IMMUNOLOGIC; ALLERGENS; ANIMALS; BRADYKININ; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; BUDESONIDE; CYCLOSPORINS; MALE; METHACHOLINE CHLORIDE; OVALBUMIN; RATS; RATS, INBRED BN; SIROLIMUS;

EID: 0041659018     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0767-7     Document Type: Article

References (52)

1. Abraham RT (1998) Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signalling. Curr Opin Immunol 10:330-336
2. Barnes PJ (1998) Pharmacology of airway smooth muscle. Am J Respir Crit Care Med 158:S123-S132
3. Barnes PJ, Fan Chung K, Page CP (1998) Inflammatory mediators of asthma: an update. Pharmacol Rev 50:515-596
4. Beckmann N, Tigani B, Ekatodramis D, Borer R, Mazzoni L, Fozard JR (2001) Pulmonary edema induced by allergen challenge in the rat: non-invasive assessment by magnetic resonance imaging. Magn Reson Med 45:88-95
5. Cissel DS, Beaven MA (2000) Disruption of Raf-1/heat shock protein 90 complex and Raf signaling by dexamethasone in mast cells. J Biol Chem 275:7066-7070
6. Cockcroft DW (1997) Airway responsiveness. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ (eds) Asthma. Lippencourt-Raven, New York, pp 1253-1266
7. De Paulis A, Cirillo R, Ciccarelli A, De Crescenzo G, Oriente A, Marone G (1991) Characterization of the anti-inflammatory effect of FK-506 on human mast cells. J Immunol 147:4278-4285
8. De Paulis A, Stellato C, Cirillo R, Ciccarelli A, Oriente A (1992) Anti-inflammatory effect of FKS06 on human skin mast cells. J Invest Dermatol 99:723-728
9. Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Sigal NH (1990) Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J Immunol 144:251-258
10. Ellis KM, Mazzoni L, Fozard JR (2002) Mechanism of the bronchoconstrictor response to bradykinin augmented following allergen challenge in actively sensitised Brown Norway rats. Br J Pharmacol 135:153P
11. Elwood W, Lötval JO, Barnes PJ, Fan Chung K (1992) Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitised Brown Norway rats. Am Rev Respir Dis 145:1289-1294
12. Eum SY, Zuany-Amorim C, Lefort J, Pretolani M, Vargaftig BB (1997) Inhibition by the immunosuppressive agent FK-506 of antigen-induced airways eosinophilia and bronchial hyperreactivity in mice. Br J Pharmacol 120:130-136
13. Fozard JR, Hannon JP (2000) Species differences in adenosine receptor-mediated bronchoconstriction responses. Clin Exp Allergy 30:1213-1220
14. Fuller RW, Choudry NB, Eriksson G (1991) Action of budesonide on asthmatic bronchial hyperresponsiveness. Effects on directly and indirectly acting bronchoconstrictors. Chest 100:670-674
15. Hannon JP (2000) Mechanism of airway hyperreactivity to adenosine, induced by allergen challenge, in the actively sensitised Brown Norway rats. PhD Thesis, University of London
16. Hannon JP, Tigani B, Mazzoni L, Fozard JR (1999) Mechanism of airway hyperreactivity to adenosine induced by allergen challenge in actively sensitised Brown Norway rats. Br J Pharmacol 127:76P
17. Hannon JP, Tigani B, Williams I, Mazzoni L, Fozard JR (2001) Mechanism of airway hyperresponsiveness to adenosine induced by allergen challenge in actively sensitised Brown Norway rats. Br J Pharmacol 132:1509-1523
18. Hannon JP, Tigani B, Wolber C, Williams I, Mazzoni L, Howes C, Fozard JR (2002) Evidence for an atypical receptor mediating the augmented bronchoconstrictor response to adenosine induced by allergen challenge in actively sensitised Brown Norway rats. Br J Pharmacol 135:685-696
19. Hatfield SJ, Roehm NW (1992) Cyclosporin and FK506 inhibition of murine mast cell cytokine production. J Pharmacol Exp Ther 260:680-688
20. Hiestand PC, Graber M, Hurtenbach U, Herrmann P, Cammisuli S, Richardson BP, Eberle MK, Borel JF (1992) The new cyclosporine derivative, SDZ IMM125: in vitro and in vivo pharmacologic effects. Transplant Proc 24:31-38
21. Ho S, Clipstone N, Timmerman L, Northrop J, Graef I, Fiorentino D, Nourse J, Crabtree GR (1996) The mechanism of action of Cyclosporin A and FK506. Clin Immunol Immunopathol 80:S40-S45
22. Hultsch T, Albers MW, Schreiber SL, Hohman RJ (1991) Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription. Proc Natl Acad Sci USA 88:6229-6233
23. Hultsch T, Martin R, Hohman R (1992) The effect of the immunophilin ligands rapamycin and FK506 on proliferation of mast cells and other hematopoietic cell lines. Mol Biol Cell 3:981-987
24. Hultsch T, Brand P, Lohmann S, Saloga J, Kincaid RL, Knop J (1998a) Direct evidence that FK506 inhibition of FcεRI-mediated exocytosis from RBL mast cells involves calcineurin. Arch Dermatol Res 290:258-263
25. Hultsch T, Muller KD, Meingassner JG, Grassberger M, Schopf RE, Knop J (1998b) Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner. Arch Dermatol Res 290:501-507
26. Ishizuka T, Kawasome H, Terada N, Takeda K, Gerwins P, Keller GM, Johnson GL, Gelfand EW (1998) Stem cell factor augments FcεRI-mediated TNF-α production and stimulates MAP kinases via a different pathway in MC/9 mast cells. J Immunol 161:3624-3630
27. Ishizuka T, Chayama K, Takeda K, Hamelmann E, Terada N, Keller GM, Johnson GL, Gelfand EW (1999) Mitogen-activated protein kinase activation through Fcε receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. J Immunol 162:2087-2094
28. 2 muscarinic receptor expression and function in the airways. Am J Respir Cell Mol Biol 24:485-491
29. Kaye RE, Fruman DA, Bierer BE, Alberts MW, Zydowski LD, Ho SI, Jin YJ, Castells MC, Schreiber SL (1992) Effects of cyclosporin A and FK506 in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK50-binding protein FKBP12. Proc Natl Acad Sci USA 89:8542-8546
30. Keller ST, Hersperger R, Della Cioppa G (2001) Macrocyclic immunosuppressants. In: Hansel TT, Barnes PJ (eds) New drugs for asthma, allergy and COPD. Karger, Basel, pp 237-240
31. Ketchell RI, Jensen MW, Lumley P, Wright AM, Allenby MI, O'Connor BJ (2002) Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5′-monophosphate in mild asthma. J Allergy Clin Immunol 110:603-606
32. Maines LW, Polavarapu R, Lakoski JM (1998) Expression of brain Gi protein in the aging F344 rat following exposure to corticosterone. Int J Dev Neurosci 16:341-346
33. Muma NA, Beck SG (1999) Corticosteroids alter G protein inwardly rectifying potassium channels protein levels in hippocampal subfields. Brain Res 839:331-335
34. Nagai H, Yamaguchi S, Tanaka H, Inagaki N (1995) Effect of some immunosuppressors on allergic bronchial inflammation and airway hyperresponsiveness in mice. Int Arch Allergy Immunol 108:189-195
35. Nogueira de Francischi J, Conroy DM, Maghni K, Sirois P (1993) Inhibition by rapamycin of leukocyte migration and bronchial hyperreactivity induced by injection of Sephadex beads to guinea-pigs. Br J Pharmacol 10:1381-1386
36. Palser A, Hannon JP, Tigani B, Mazzoni L, Fozard JR (2000) Time-dependent changes in bronchial responsiveness to direct and indirect bronchospasmogens following allergen challenge in actively sensitised Brown Norway rats. Br J Pharmacol 131:117P
37. Pauwels R (1997) Bronchial hyperresponsiveness. In: Kay AB (eds) Allergy and allergic diseases. Blackwell Scientific, Oxford, pp 682-691
38. Rider LG, Hirasawa N, Santini F, Beaven MA (1996) Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. J Immunol 157:2374-2380
39. Robin JL, Seldin DC, Austen KF, Lewis RA (1985) Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. J Immunol 135:2719-2726
40. Sawada S, Suzuki G, Kawase Y, Takaku F (1987) Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol 139:1797-1803
41. Schreiber SL, Crabtree GR (1992) The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136-142
42. Sedrani R, Cottens S, Kallen J, Schuler W (1998) Chemical modification of rapamycin: the discovery of SDZ RAD. Transplant Proc 30:2192-2194
43. Sewell WA, Scurr LL, Orphanides H, Kinder S, Ludowyke RI (1998) Induction of interleukin-4 and interleukin-5 expression in mast cells is inhibited by glucocorticoids. Clin Diagn Lab Immunol 5:18-23
44. Shevach EM (1985) The effects of cyclosporin A on the immune system. Annu Rev Immunol 3:397-423
45. Sperr WR, Agis H, Czerwenka K, Virgolini I, Bankl HC, Muller, MR, Zsebo K, Lechner K, Valent P (1996) Effects of cyclosporin A and FK506 on stem cell factor-induced histamine secretion and growth of human mast cells. J Allergy Clin Immunol 98:389-399
46. Stellato C, De Paulis A, Ciccarelli A, Cirillo R, Patella V, Casolaro V, Marone G (1992) Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol 98:800-804
47. Taylor AM, Galli SJ, Coleman JW (1996) Dexamethasone or cyclosporine A inhibits stem cell factor-dependant secretory responses of rat peritoneal mast cells in vitro. Immunopharmacology 34:63-70
48. Tigani B, Hannon JP, Mazzoni L, Fozard JR (2001) Effects of budesonide and IMM125 on antigen-induced airway inflammation and hyperresponsiveness to adenosine in actively sensitised Brown Norway rats. Br J Pharmacol 133:41P
49. Toyota N, Hashimoto Y, Matsuo S, Kitamura Y, Iisuza H (1996) Effects of FK506 and cyclosporin A on proliferation, histamine release and phenotype of murine mast cells. Arch Dermatol Res 288:474-480
50. Van Schoor J, Joos GF, Pauwels RA (2000) Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. Eur Respir J 16:514-533
51. Warbrick EV, Thomas AL, Williams CMM (1997) The effects of cyclosporin A, dexamethasone and other immunomodulatory drugs on induced expression of IL-3, IL-4 and IL-8 mRNA in a human mast cell line. Toxicology 116:211-218
52. Wershil BK, Furuta GT, Lavigne JA, Choudhury AR, Wang ZS, Gall JS (1995) Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse. J Immunol 154:1391-1398